Physiological Performance and Cardiac Function in Female Ironman- Triathletes
American Journal of Sports Science
Volume 2, Issue 2, March 2014, Pages: 41-47
Received: Mar. 10, 2014; Published: Mar. 30, 2014
Views 2883      Downloads 142
Authors
Roman Leischik, Department of Cardiology, Section Prevention and Sports Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany
Spelsberg N., Department of Cardiology, Section Prevention and Sports Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany
Littwitz H., Department of Cardiology, Section Prevention and Sports Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany
Dworrak B., Department of Cardiology, Section Prevention and Sports Medicine, Faculty of Health, School of Medicine, Witten/Herdecke University, Witten, Germany
Article Tools
PDF
Follow on us
Abstract
Background: Data about physiological performance of female ironman-triathletes are rare. However, some papers reported endurance sport may cause damage of the right or left ventricle even in females. Aim: The goal of this study was to assess prospectively the right/left ventricular function and physiological performance in female ironman-athletes (middle- and long-distance). Methods: 33 female healthy triathletes were examined using spiroergometry and echocardiography. Inclusion criterion was participation in at least one middle distance triathlon. Results: The triathletes achieved the following results: VO2max 52.8 ± 5.7 ml/min/kg, Wmax 264.0 ± 26.1, VAT (aerobic threshold) VO2 38.5 ± 7.9 ml/min/kg, 193.0 ± 48.4 Watt. In respect of echocardiographic readings LVEDD (left ventricular end-diastolic diameter) was 4.4 ± 0.3 cm and the left ventricular muscle mass (LVM) was 145.9 ± 31.3 g (LVM index 85.8 g/m² ± 18.7). Conclusions: The performance date of female triathletes can be used as training goals for leisure female triathletes, when middle or long distances in triathlon competitions should be finished. In respect of echocardiographic parameters a right or left ventricular dysfunction could not be found despite of long times of training and finishing of long distance competitions (5.4 ± 2.8 years triathlon competitions non-elite and 7.6 ± 5.8 years elite athletes).
Keywords
Triathlon, Ironman, Cardiac Fatigue, Female Athletes
To cite this article
Roman Leischik, Spelsberg N., Littwitz H., Dworrak B., Physiological Performance and Cardiac Function in Female Ironman- Triathletes, American Journal of Sports Science. Vol. 2, No. 2, 2014, pp. 41-47. doi: 10.11648/j.ajss.20140202.16
References
[1]
Triathlon, U. Demographics, Triathlon participation, growth trends and demographics. 2013 (updated April 2013); Available from: http://www.usatriathlon.org/about-multisport/demographics.aspx.
[2]
La Gerche, A., A.T. Burns, D.J. Mooney, W.J. Inder, A.J. Taylor, J. Bogaert, A.I. MacIsaac, H. Heidbüchel and D.L. Prior, Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. European heart journal, 2012. 33(8): p. 998-1006.
[3]
Douglas, P.S., M.L. O'Toole, W.D. Hiller, K. Hackney and N. Reichek, Cardiac fatigue after prolonged exercise. Circulation, 1987. 76(6): p. 1206-13.
[4]
Harris, K.M., J.T. Henry, E. Rohman, T.S. Haas and B.J. Maron, Sudden death during the triathlon. Jama, 2010. 303(13): p. 1255-7.
[5]
Suriano, R. and D. Bishop, Physiological attributes of triathletes. J Sci Med Sport, 2010. 13(3): p. 340-7.
[6]
Sleivert, G.G. and D.S. Rowlands, Physical and physiological factors associated with success in the triathlon. Sports Med, 1996. 22(1): p. 8-18.
[7]
O'Toole, M.L. and P.S. Douglas, Applied physiology of triathlon. Sports Med, 1995. 19(4): p. 251-67.
[8]
O'Toole, M.L., D.B. Hiller, L.O. Crosby and P.S. Douglas, The ultraendurance triathlete: a physiological profile. Med Sci Sports Exerc, 1987. 19(1): p. 45-50.
[9]
O'Toole, M.L., P.S. Douglas and W.D. Hiller, Lactate, oxygen uptake, and cycling performance in triathletes. Int J Sports Med, 1989. 10(6): p. 413-8.
[10]
Kohrt, W.M., D.W. Morgan, B. Bates and J.S. Skinner, Physiological responses of triathletes to maximal swimming, cycling, and running. Med Sci Sports Exerc, 1987. 19(1): p. 51-5.
[11]
Butts, N.K., B.A. Henry and D. McLean, Correlations between VO2max and performance times of recreational triathletes. J Sports Med Phys Fitness, 1991. 31(3): p. 339-44.
[12]
Sleivert, G.G. and H.A. Wenger, Physiological predictors of short-course triathlon performance. Med Sci Sports Exerc, 1993. 25(7): p. 871-6.
[13]
Schabort, E.J., S.C. Killian, A. St Clair Gibson, J.A. Hawley and T.D. Noakes, Prediction of triathlon race time from laboratory testing in national triathletes. Med Sci Sports Exerc, 2000. 32(4): p. 844-9.
[14]
Douglas, P.S., M.L. O'Toole, S.E. Katz, G.S. Ginsburg, W.D. Hiller and R.H. Laird, Left ventricular hypertrophy in athletes. Am J Cardiol, 1997. 80(10): p. 1384-8.
[15]
Lang, R.M., M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward and J. Shanewise, Recommendations for chamber quantification. European Journal of Echocardiography, 2006. 7(2): p. 79-108.
[16]
Laurenson, N.M., K.Y. Fulcher and P. Korkia, Physiological characteristics of elite and club level female triathletes during running. Int J Sports Med, 1993. 14(8): p. 455-9.
[17]
Atchley, A.E., Jr. and P.S. Douglas, Left ventricular hypertrophy in athletes: morphologic features and clinical correlates. Cardiol Clin, 2007. 25(3): p. 371-82, v.
[18]
George, K.P., L.A. Wolfe and G.W. Burggraf, The 'athletic heart syndrome'. A critical review. Sports Med, 1991. 11(5): p. 300-30.
[19]
Dickhuth, H., A. Hipp, A. Niess, K. Röcker, F. Mayer and T. Horstmann, Differenzialdiagnostik der physiologischen Herzhypertrophie (Sportherz). DEUTSCHE ZEITSCHRIFT FÜR SPORTMEDIZIN, 2001. 52(6): p. 205-210.
[20]
Henschen, S., Skilanglauf und Skiwettlauf. Eine medizinische Sportstudie. Mitt Med Klin Upsala, 1899:. 2:: p. 74.
[21]
Whyte, G.P., K. George, A. Nevill, R. Shave, S. Sharma and W.J. McKenna, Left ventricular morphology and function in female athletes: a meta-analysis. Int J Sports Med, 2004. 25(5): p. 380-3.
[22]
Douglas, P.S., Cardiac considerations in the triathlete. Med Sci Sports Exerc, 1989. 21(5 Suppl): p. S214-8.
[23]
Pelliccia, A., B.J. Maron, A. Spataro, M.A. Proschan and P. Spirito, The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med, 1991. 324(5): p. 295-301.
[24]
Pluim, B.M., A.H. Zwinderman, A. van der Laarse and E.E. van der Wall, The athlete’s heart a meta-analysis of cardiac structure and function. Circulation, 2000. 101(3): p. 336-344.
[25]
Fagard, R., A. Aubert, J. Staessen, E.V. Eynde, L. Vanhees and A. Amery, Cardiac structure and function in cyclists and runners. Comparative echocardiographic study. Br Heart J, 1984. 52(2): p. 124-9.
[26]
Hoogsteen, J., A. Hoogeveen, H. Schaffers, P.F. Wijn and E.E. van der Wall, Left atrial and ventricular dimensions in highly trained cyclists. Int J Cardiovasc Imaging, 2003. 19(3): p. 211-7.
[27]
Marijon, E., M. Tafflet, D.S. Celermajer, F. Dumas, M.C. Perier, H. Mustafic, J.F. Toussaint, M. Desnos, M. Rieu, N. Benameur, J.Y. Le Heuzey, J.P. Empana, and X. Jouven, Sports-related sudden death in the general population. Circulation, 2011. 124(6): p. 672-81.
[28]
Solberg, E.E., F. Gjertsen, E. Haugstad and L. Kolsrud, Sudden death in sports among young adults in Norway. Eur J Cardiovasc Prev Rehabil, 2010. 17(3): p. 337-41.
[29]
Maron, B.J., P.D. Thompson, M.J. Ackerman, G. Balady, S. Berger, D. Cohen, R. Dimeff, P.S. Douglas, D.W. Glover and A.M. Hutter, Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation, 2007. 115(12): p. 1643-1655.
[30]
Corrado, D., C. Basso, G. Rizzoli, M. Schiavon and G. Thiene, Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol, 2003. 42(11): p. 1959-63.
[31]
Rifai, N., P.S. Douglas, M. O'Toole, E. Rimm and G.S. Ginsburg, Cardiac troponin T and I, echocardiographic [correction of electrocardiographic] wall motion analyses, and ejection fractions in athletes participating in the Hawaii Ironman Triathlon. Am J Cardiol, 1999. 83(7): p. 1085-9.
[32]
Hue, O., Prediction of drafted-triathlon race time from submaximal laboratory testing in elite triathletes. Can J Appl Physiol, 2003. 28(4): p. 547-60.
[33]
Bunc, V., J. Heller, J. Horcic and J. Novotny, Physiological profile of best Czech male and female young triathletes. J Sports Med Phys Fitness, 1996. 36(4): p. 265-70.
[34]
O'Keefe, J.H., R.P. Harshal, C.J. Lavie, A. Magalski, R.A. Vogel and P.A. McCiiough, Potential Adverse Cardiovascular Effects From Excessive Endurance Exercise. Mayo Clin Proc., 2012. 87(6): p. 587-595.
[35]
Oxborough, D., K. Birch, R. Shave and K. George, "Exercise-induced cardiac fatigue"--a review of the echocardiographic literature. Echocardiography, 2010. 27(9): p. 1130-40.
[36]
Marijon, E., W. Bougouin, M.C. Perier, D.S. Celermajer and X. Jouven, Incidence of sports-related sudden death in France by specific sports and sex. Jama, 2013. 310(6): p. 642-3.
[37]
Andersen, K., B. Farahmand, A. Ahlbom, C. Held, S. Ljunghall, K. Michaelsson and J. Sundstrom, Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J, 2013.
[38]
Leischik, R., B. Dworrak, H. Littwitz and H. Gulker, Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study). Int J Cardiol, 2007. 119(3): p. 297-305.
[39]
Leischik, R. Ugly duckling or Nosferatu ? - marathon running and cardiovascular function How to screen the athletes? 2014; Available from: http://eurheartj.oxfordjournals.org/content/early/2014/01/08/eurheartj.eht502/reply#ehj_el_2040.
[40]
La Gerche, A., A.L. Baggish, J. Knuuti, D.L. Prior, S. Sharma, H. Heidbuchel and P.D. Thompson, Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging, 2013. 6(9): p. 993-1007.
[41]
Pelliccia, A., N. Kinoshita, C. Pisicchio, F. Quattrini, F.M. DiPaolo, R. Ciardo, B. Di Giacinto, E. Guerra, E. De Blasiis, M. Casasco, F. Culasso and B.J. Maron, Long-Term Clinical Consequences of Intense, Uninterrupted Endurance Training in Olympic Athletes. Journal of the American College of Cardiology, 2010. 55(15): p. 1619-1625.
[42]
Organisation, W.H. Global Health Risks. 2009; Page 17,18, : Available from: http://www.who.int/healthinfo/global_burden_disease/GlobalHealthRisks_report_full.pdf.
[43]
Warburton, D.E., C.W. Nicol and S.S. Bredin, Health benefits of physical activity: the evidence. Cmaj, 2006. 174(6): p. 801-9.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186